Jan. 4 (Bloomberg) -- D. Medical Industries Ltd. surged the most in more than a month after the maker of drug delivery devices said its infusion set was listed in a U.S. diabetes consumer guide.
The shares rose 2.5 percent, the biggest gain since Nov. 30, to 5.27 shekels at the 4:30 p.m. close in Tel Aviv, giving the Tirat Carmel, Israel-based company a market value of 43 million shekels ($11 million).
D. Medical said its Spring Universal Infusion Set for the monitoring of insulin delivery has been listed in the American Diabetes Association 2012 Consumer Guide, according to a filing with the Tel Aviv Stock Exchange today.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org